passages.id: split_5_test_212_passage
passages.type: progene_text
passages.text: Study patients were randomly divided into four parallel groups to receive either terbinafine 250 mg a day for 12 or 16 weeks ( groups T12 and T16 ) or itraconazole 400 mg a day for 1 week in every 4 weeks for 12 or 16 weeks ( groups I3 and I4 ) .